SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Pedro A. Dionísio, Joana D. Amaral, Maria F. Ribeiro, Adrian C. Lo, Rudi D'Hooge, Cecília M.P. Rodrigues, Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset, Neurobiology of Aging, 2015, 36, 1, 228

    CrossRef

  2. 2
    Byung Hee Han, Meng-liang Zhou, Andrew W. Johnson, Itender Singh, Fan Liao, Ananth K. Vellimana, James W. Nelson, Eric Milner, John R. Cirrito, Jacob Basak, Min Yoo, Hans H. Dietrich, David M. Holtzman, Gregory Joseph Zipfel, Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice, Proceedings of the National Academy of Sciences, 2015, 112, 8, E881

    CrossRef

  3. 3
    Amélie Béduer, Pierre Joris, Sébastien Mosser, Patrick C Fraering, Philippe Renaud, Detection of Alzheimer’s disease amyloid-beta plaque deposition by deep brain impedance profiling, Journal of Neural Engineering, 2015, 12, 2, 024001

    CrossRef

  4. 4
    Chaoyun Li, Caroline Zug, Hongchun Qu, Hermann Schluesener, Zhiyuan Zhang, Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice, Behavioural Brain Research, 2015, 281, 32

    CrossRef

  5. 5
    Ann-Marie Waldron, Jeroen Verhaeghe, Leonie wyffels, Mark Schmidt, Xavier Langlois, Annemie Van Der Linden, Sigrid Stroobants, Steven Staelens, Preclinical Comparison of the Amyloid-β Radioligands [11C]Pittsburgh compound B and [18F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis, Molecular Imaging and Biology, 2015,

    CrossRef

  6. 6
    Manuela Ariza, Hartmuth C. Kolb, Dieder Moechars, Frederik Rombouts, José Ignacio Andrés, Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future, Journal of Medicinal Chemistry, 2015, 150225135201002

    CrossRef

  7. 7
    Tine Pooters, Ann Van der Jeugd, Zsuzsanna Callaerts-Vegh, Rudi D’Hooge, Telencephalic neurocircuitry and synaptic plasticity in rodent spatial learning and memory, Brain Research, 2015,

    CrossRef

  8. 8
    S. Mosser, J.-R. Alattia, M. Dimitrov, A. Matz, J. Pascual, B. L. Schneider, P. C. Fraering, The adipocyte differentiation protein APMAP is an endogenous suppressor of A  production in the brain, Human Molecular Genetics, 2015, 24, 2, 371

    CrossRef

  9. 9
    T. R. Jay, C. M. Miller, P. J. Cheng, L. C. Graham, S. Bemiller, M. L. Broihier, G. Xu, D. Margevicius, J. C. Karlo, G. L. Sousa, A. C. Cotleur, O. Butovsky, L. Bekris, S. M. Staugaitis, J. B. Leverenz, S. W. Pimplikar, G. E. Landreth, G. R. Howell, R. M. Ransohoff, B. T. Lamb, TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models, Journal of Experimental Medicine, 2015,

    CrossRef

  10. 10
    Shuang Wang, Yang Yu, Shuang Geng, Dongmei Wang, Li Zhang, Xiaoping Xie, Bing Wu, Chaofan Li, Hanqian Xu, Xiaolin Li, Yanxin Hu, Lianfeng Zhang, Christoph Kaether, Bin Wang, A coimmunization vaccine of Aβ42 ameliorates cognitive deficits without brain inflammation in an Alzheimer’s disease model, Alzheimer's Research & Therapy, 2014, 6, 3, 26

    CrossRef

  11. 11
    C. Cook, Y. Carlomagno, T. F. Gendron, J. Dunmore, K. Scheffel, C. Stetler, M. Davis, D. Dickson, M. Jarpe, M. DeTure, L. Petrucelli, Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance, Human Molecular Genetics, 2014, 23, 1, 104

    CrossRef

  12. 12
    Jason D Ulrich, Mary Finn, Yaming Wang, Alice Shen, Thomas E Mahan, Hong Jiang, Floy R Stewart, Laura Piccio, Marco Colonna, David M Holtzman, Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2, Molecular Neurodegeneration, 2014, 9, 1, 20

    CrossRef

  13. 13
    Sarah K. Fritschi, Amarallys Cintron, Lan Ye, Jasmin Mahler, Anika Bühler, Frank Baumann, Manuela Neumann, K. Peter R. Nilsson, Per Hammarström, Lary C. Walker, Mathias Jucker, Aβ seeds resist inactivation by formaldehyde, Acta Neuropathologica, 2014, 128, 4, 477

    CrossRef

  14. 14
    S Liebscher, R M Page, K Käfer, E Winkler, K Quinn, E Goldbach, E F Brigham, D Quincy, G S Basi, D B Schenk, H Steiner, T Bonhoeffer, C Haass, M Meyer-Luehmann, M Hübener, Chronic γ-secretase inhibition reduces amyloid plaque-associated instability of pre- and postsynaptic structures, Molecular Psychiatry, 2014, 19, 8, 937

    CrossRef

  15. 15
    H. Lison, M.F.K. Happel, F. Schneider, K. Baldauf, S. Kerbstat, B. Seelbinder, J. Schneeberg, M. Zappe, J. Goldschmidt, E. Budinger, U.H. Schröder, F.W. Ohl, S. Schilling, H.-U. Demuth, H. Scheich, K.G. Reymann, R. Rönicke, Disrupted cross-laminar cortical processing in β amyloid pathology precedes cell death, Neurobiology of Disease, 2014, 63, 62

    CrossRef

  16. 16
    Andras Bilkei-Gorzo, Genetic mouse models of brain ageing and Alzheimer's disease, Pharmacology & Therapeutics, 2014, 142, 2, 244

    CrossRef

  17. 17
    Jan Klohs, Markus Rudin, Derya R. Shimshek, Nicolau Beckmann, Imaging of cerebrovascular pathology in animal models of Alzheimer's disease, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  18. 18
    Bianca Brawek, Bernd Schwendele, Karin Riester, Shinichi Kohsaka, Chommanad Lerdkrai, Yajie Liang, Olga Garaschuk, Impairment of in vivo calcium signaling in amyloid plaque-associated microglia, Acta Neuropathologica, 2014, 127, 4, 495

    CrossRef

  19. 19
    Yuki Kuwabara, Masato Ishizeki, Naoto Watamura, Junya Toba, Aya Yoshii, Takafumi Inoue, Toshio Ohshima, Impairments of long-term depression induction and motor coordination precede Aβ accumulation in the cerebellum of APPswe/PS1dE9 double transgenic mice, Journal of Neurochemistry, 2014, 130, 3
  20. 20
    Steffen Burgold, Severin Filser, Mario M Dorostkar, Boris Schmidt, Jochen Herms, In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques, Acta Neuropathologica Communications, 2014, 2, 1, 30

    CrossRef

  21. 21
    Eugenio Barone, Sebastien Mosser, Patrick C. Fraering, Inactivation of brain Cofilin-1 by age, Alzheimer's disease and γ-secretase, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014, 1842, 12, 2500

    CrossRef

  22. 22
    Hope Y. Agbemenyah, Roberto C. Agis-Balboa, Susanne Burkhardt, Ivana Delalle, Andre Fischer, Insulin growth factor binding protein 7 is a novel target to treat dementia, Neurobiology of Disease, 2014, 62, 135

    CrossRef

  23. 23
    Javier Becerril-Ortega, Karim Bordji, Thomas Fréret, Travis Rush, Alain Buisson, Iron overload accelerates neuronal amyloid-β production and cognitive impairment in transgenic mice model of Alzheimer's disease, Neurobiology of Aging, 2014, 35, 10, 2288

    CrossRef

  24. 24
    Paula L. McClean, Christian Hölscher, Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease, Neuropharmacology, 2014, 76, 57

    CrossRef

  25. 25
    Paula L. McClean, Christian Hölscher, Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease, Neuropharmacology, 2014, 86, 241

    CrossRef

  26. 26
    Florian C Maier, Hans F Wehrl, Andreas M Schmid, Julia G Mannheim, Stefan Wiehr, Chommanad Lerdkrai, Carsten Calaminus, Anke Stahlschmidt, Lan Ye, Michael Burnet, Detlef Stiller, Osama Sabri, Gerald Reischl, Mathias Staufenbiel, Olga Garaschuk, Mathias Jucker, Bernd J Pichler, Longitudinal PET-MRI reveals β-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion, Nature Medicine, 2014, 20, 12, 1485

    CrossRef

  27. 27
    Christian Bigot, Greetje Vanhoutte, Marleen Verhoye, Annemie Van der Linden, Magnetization transfer contrast imaging reveals amyloid pathology in Alzheimer's disease transgenic mice, NeuroImage, 2014, 87, 111

    CrossRef

  28. 28
    Andrea Delekate, Martina Füchtemeier, Toni Schumacher, Cordula Ulbrich, Marco Foddis, Gabor C. Petzold, Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer’s disease mouse model, Nature Communications, 2014, 5, 5422

    CrossRef

  29. 29
    Kira Irving Mosher, Tony Wyss-Coray, Microglial dysfunction in brain aging and Alzheimer's disease, Biochemical Pharmacology, 2014, 88, 4, 594

    CrossRef

  30. 30
    Eduardo R. Zimmer, Maxime J. Parent, A. Claudio Cuello, Serge Gauthier, Pedro Rosa-Neto, MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research, Trends in Neurosciences, 2014, 37, 11, 629

    CrossRef

  31. 31
    J. H. Roh, H. Jiang, M. B. Finn, F. R. Stewart, T. E. Mahan, J. R. Cirrito, A. Heda, B. J. Snider, M. Li, M. Yanagisawa, L. de Lecea, D. M. Holtzman, Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease, Journal of Experimental Medicine, 2014, 211, 13, 2487

    CrossRef

  32. 32
    Andrea Jarre, Nina S. Gowert, Lili Donner, Patrick Münzer, Meike Klier, Oliver Borst, Martin Schaller, Florian Lang, Carsten Korth, Margitta Elvers, Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease, Cellular Signalling, 2014, 26, 9, 2040

    CrossRef

  33. 33
    Suya Sun, Hua Zhang, Jie Liu, Elena Popugaeva, Nan-Jie Xu, Stefan Feske, Charles L. White, Ilya Bezprozvanny, Reduced Synaptic STIM2 Expression and Impaired Store-Operated Calcium Entry Cause Destabilization of Mature Spines in Mutant Presenilin Mice, Neuron, 2014, 82, 1, 79

    CrossRef

  34. 34
    Anja Brenn, Markus Grube, Gabriele Jedlitschky, Andrea Fischer, Barbara Strohmeier, Martin Eiden, Markus Keller, Martin H. Groschup, Silke Vogelgesang, St. John's Wort Reduces Beta-Amyloid Accumulation in a Double Transgenic Alzheimer's Disease Mouse Model—Role of P-Glycoprotein, Brain Pathology, 2014, 24, 1
  35. 35
    Christian Hölscher, The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease, Alzheimer's & Dementia, 2014, 10, 1, S47

    CrossRef

  36. 36
    Jie Liu, Charlene Supnet, Suya Sun, Hua Zhang, Levi Good, Elena Popugaeva, Ilya Bezprozvanny, The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease, Channels, 2014, 8, 3, 230

    CrossRef

  37. 37
    Nevena Djogo, Igor Jakovcevski, Christian Müller, Hyun Joon Lee, Jin-Chong Xu, Mira Jakovcevski, Sebastian Kügler, Gabriele Loers, Melitta Schachner, Adhesion molecule L1 binds to amyloid beta and reduces Alzheimer's disease pathology in mice, Neurobiology of Disease, 2013, 56, 104

    CrossRef

  38. 38
    Christian Czech, Fiona Grueninger, Animal models for Alzheimer's disease – the industry perspective, Drug Discovery Today: Therapeutic Strategies, 2013, 10, 2, e73

    CrossRef

  39. 39
    Sylvain E. Lesné, Breaking the Code of Amyloid- Oligomers, International Journal of Cell Biology, 2013, 2013, 1

    CrossRef

  40. 40
    L. F. Maia, S. A. Kaeser, J. Reichwald, M. Hruscha, P. Martus, M. Staufenbiel, M. Jucker, Changes in Amyloid-  and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein, Science Translational Medicine, 2013, 5, 194, 194re2

    CrossRef

  41. 41
    Ina Tesseur, Anna A. Pimenova, Adrian C. Lo, Marta Ciesielska, Stefan F. Lichtenthaler, Joris H. De Maeyer, Jan A.J. Schuurkes, Rudi D'Hooge, Bart De Strooper, Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice, Neurobiology of Aging, 2013, 34, 7, 1779

    CrossRef

  42. 42
    Joanna F. McCarter, Sabine Liebscher, Teresa Bachhuber, Claudia Abou-Ajram, Mark Hübener, Bradley T. Hyman, Christian Haass, Melanie Meyer-Luehmann, Clustering of plaques contributes to plaque growth in a mouse model of Alzheimer’s disease, Acta Neuropathologica, 2013, 126, 2, 179

    CrossRef

  43. 43
    I. Tesseur, A. C. Lo, A. Roberfroid, S. Dietvorst, B. Van Broeck, M. Borgers, H. Gijsen, D. Moechars, M. Mercken, J. Kemp, R. D'Hooge, B. De Strooper, Comment on "ApoE-Directed Therapeutics Rapidly Clear  -Amyloid and Reverse Deficits in AD Mouse Models", Science, 2013, 340, 6135, 924

    CrossRef

  44. 44
    K. Veeraraghavalu, C. Zhang, S. Miller, J. K. Hefendehl, T. W. Rajapaksha, J. Ulrich, M. Jucker, D. M. Holtzman, R. E. Tanzi, R. Vassar, S. S. Sisodia, Comment on "ApoE-Directed Therapeutics Rapidly Clear  -Amyloid and Reverse Deficits in AD Mouse Models", Science, 2013, 340, 6135, 924

    CrossRef

  45. 45
    Ayodeji A. Asuni, Joanna E. Pankiewicz, Martin J. Sadowski, Differential molecular chaperone response associated with various mouse adapted scrapie strains, Neuroscience Letters, 2013, 538, 26

    CrossRef

  46. 46
    Greetje Vanhoutte, Sandra Pereson, Rafael Delgado y Palacios, Pieter-Jan Guns, Bob Asselbergh, Jelle Veraart, Jan Sijbers, Marleen Verhoye, Christine Broeckhoven, Annemie Linden, Diffusion kurtosis imaging to detect amyloidosis in an APP/PS1 mouse model for Alzheimer's disease, Magnetic Resonance in Medicine, 2013, 69, 4
  47. 47
    Adrian C. Lo, Ina Tesseur, David I.C. Scopes, Edmund Nerou, Zsuzsanna Callaerts-Vegh, Ben Vermaercke, J. Mark Treherne, Bart De Strooper, Rudi D'Hooge, Dose-dependent improvements in learning and memory deficits in APPPS1-21 transgenic mice treated with the orally active Aβ toxicity inhibitor SEN1500, Neuropharmacology, 2013, 75, 458

    CrossRef

  48. 48
    Anne Corbett, Gareth Williams, Clive Ballard, Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease, Pharmaceuticals, 2013, 6, 10, 1304

    CrossRef

  49. 49
    Gwendolyn Behrendt, Kristin Baer, Annalisa Buffo, Maurice A. Curtis, Richard L. Faull, Mark I. Rees, Magdalena Götz, Leda Dimou, Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men, Glia, 2013, 61, 2
  50. 50
    André ES Simões, Diane M Pereira, Joana D Amaral, Ana F Nunes, Sofia E Gomes, Pedro M Rodrigues, Adrian C Lo, Rudi D'Hooge, Clifford J Steer, Stephen N Thibodeau, Pedro M Borralho, Cecília MP Rodrigues, Efficient recovery of proteins from multiple source samples after trizol® or trizol®LS RNA extraction and long-term storage, BMC Genomics, 2013, 14, 1, 181

    CrossRef

  51. 51
    Sofie Nyström, Katarzyna M. Psonka-Antonczyk, Pål Gunnar Ellingsen, Leif B. G. Johansson, Nina Reitan, Susann Handrick, Stefan Prokop, Frank L. Heppner, Bettina M. Wegenast-Braun, Mathias Jucker, Mikael Lindgren, Bjørn Torger Stokke, Per Hammarström, K. Peter R. Nilsson, Evidence for Age-Dependentin VivoConformational Rearrangement within Aβ Amyloid Deposits, ACS Chemical Biology, 2013, 8, 6, 1128

    CrossRef

  52. 52
    Miriam Avadisian, Patrick T. Gunning, Extolling the benefits of molecular therapeutic lipidation, Molecular BioSystems, 2013, 9, 9, 2179

    CrossRef

  53. 53
    Yvonne S. Eisele, From Soluble Aβ to Progressive Aβ Aggregation: Could Prion-Like Templated Misfolding Play a Role?, Brain Pathology, 2013, 23, 3
  54. 54
    Christina Fröhlich, Kristin Paarmann, Johannes Steffen, Jan Stenzel, Markus Krohn, Hans-Jochen Heinze, Jens Pahnke, Genomic background-related activation of microglia and reduced β-amyloidosis in a mouse model of Alzheimer’s disease, European Journal of Microbiology and Immunology, 2013, 3, 1, 21

    CrossRef

  55. 55
    Jens Pahnke, Christina Fröhlich, Markus Krohn, Toni Schumacher, Kristin Paarmann, Impaired mitochondrial energy production and ABC transporter function—A crucial interconnection in dementing proteopathies of the brain, Mechanisms of Ageing and Development, 2013, 134, 10, 506

    CrossRef

  56. 56
    Hui-li Liu, Gang Zhao, He Zhang, Li-de Shi, Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice, Behavioural Brain Research, 2013, 256, 261

    CrossRef

  57. 57
    Zhi-Yuan Zhang, Rolf Daniels, Hermann J. Schluesener, Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis, Journal of Cellular and Molecular Medicine, 2013, 17, 12
  58. 58
    Swetlana Sirko, Gwendolyn Behrendt, Pia Annette Johansson, Pratibha Tripathi, Marcos Romualdo Costa, Sarah Bek, Christophe Heinrich, Steffen Tiedt, Dilek Colak, Martin Dichgans, Isabel Rebekka Fischer, Nikolaus Plesnila, Matthias Staufenbiel, Christian Haass, Marina Snapyan, Armen Saghatelyan, Li-Huei Tsai, André Fischer, Kay Grobe, Leda Dimou, Magdalena Götz, Reactive Glia in the Injured Brain Acquire Stem Cell Properties in Response to Sonic Hedgehog, Cell Stem Cell, 2013, 12, 4, 426

    CrossRef

  59. 59
    Nambirajan Govindarajan, Pooja Rao, Susanne Burkhardt, Farahnaz Sananbenesi, Oliver M. Schlüter, Frank Bradke, Jianrong Lu, André Fischer, Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease, EMBO Molecular Medicine, 2013, 5, 1
  60. 60
    Götz Heilbronner, Yvonne S Eisele, Franziska Langer, Stephan A Kaeser, Renata Novotny, Amudha Nagarathinam, Andreas Åslund, Per Hammarström, K Peter R Nilsson, Mathias Jucker, Seeded strain-like transmission of β-amyloid morphotypes in APP transgenic mice, EMBO reports, 2013, 14, 11
  61. 61
    Adrian C. Lo, Zsuzsanna Callaerts-Vegh, Ana F. Nunes, Cecília M.P. Rodrigues, Rudi D'Hooge, Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice, Neurobiology of Disease, 2013, 50, 21

    CrossRef

  62. 62
    Rita M. Ramalho, Ana F. Nunes, Raquel B. Dias, Joana D. Amaral, Adrian C. Lo, Rudi D'Hooge, Ana M. Sebastião, Cecilia M.P. Rodrigues, Tauroursodeoxycholic acid suppresses amyloid β-induced synaptic toxicity in vitro and in APP/PS1 mice, Neurobiology of Aging, 2013, 34, 2, 551

    CrossRef

  63. 63
    A.M. Duffy, C. Hölscher, The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer’s disease, Neuroscience, 2013, 228, 294

    CrossRef

  64. 64
    Alexi Nott, Daniel M. Fass, Stephen J. Haggarty, Li-Huei Tsai, Epigenetic Regulation in the Nervous System, 2013,

    CrossRef

  65. 65
    Anna Nemirovsky, Jenny Shapiro, Rona Baron, Alex Kompaniets, Alon Monsonego, Active Aβ vaccination fails to enhance amyloid clearance in a mouse model of Alzheimer's disease with Aβ42-driven pathology, Journal of Neuroimmunology, 2012, 247, 1-2, 95

    CrossRef

  66. 66
    Tobias Bittner, Steffen Burgold, Mario M. Dorostkar, Martin Fuhrmann, Bettina M. Wegenast-Braun, Boris Schmidt, Hans Kretzschmar, Jochen Herms, Amyloid plaque formation precedes dendritic spine loss, Acta Neuropathologica, 2012, 124, 6, 797

    CrossRef

  67. 67
    P. E. Cramer, J. R. Cirrito, D. W. Wesson, C. Y. D. Lee, J. C. Karlo, A. E. Zinn, B. T. Casali, J. L. Restivo, W. D. Goebel, M. J. James, K. R. Brunden, D. A. Wilson, G. E. Landreth, ApoE-Directed Therapeutics Rapidly Clear  -Amyloid and Reverse Deficits in AD Mouse Models, Science, 2012, 335, 6075, 1503

    CrossRef

  68. 68
    R. Lalonde, K. Fukuchi, C. Strazielle, APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD), Neuroscience & Biobehavioral Reviews, 2012, 36, 5, 1357

    CrossRef

  69. 69
    Enrica Boda, Eriola Hoxha, Alessandro Pini, Francesca Montarolo, Filippo Tempia, Brain Expression of Kv3 Subunits During Development, Adulthood and Aging and in a Murine Model of Alzheimer’s Disease, Journal of Molecular Neuroscience, 2012, 46, 3, 606

    CrossRef

  70. 70
    Konrad Talbot, Hoau-Yan Wang, Hala Kazi, Li-Ying Han, Kalindi P. Bakshi, Andres Stucky, Robert L. Fuino, Krista R. Kawaguchi, Andrew J. Samoyedny, Robert S. Wilson, Zoe Arvanitakis, Julie A. Schneider, Bryan A. Wolf, David A. Bennett, John Q. Trojanowski, Steven E. Arnold, Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline, Journal of Clinical Investigation, 2012, 122, 4, 1316

    CrossRef

  71. 71
    Anne Corbett, James Pickett, Alistair Burns, Jonathan Corcoran, Stephen B. Dunnett, Paul Edison, Jim J. Hagan, Clive Holmes, Emma Jones, Cornelius Katona, Ian Kearns, Patrick Kehoe, Amrit Mudher, Anthony Passmore, Nicola Shepherd, Frank Walsh, Clive Ballard, Drug repositioning for Alzheimer's disease, Nature Reviews Drug Discovery, 2012, 11, 11, 833

    CrossRef

  72. 72
    Rubén Vidal, Bernardino Ghetti, Generation of a novel murine model of Aβ deposition based on the expression of human wild-type amyloid precursor protein gene, Prion, 2012, 6, 4, 346

    CrossRef

  73. 73
    Harry D. Samaroo, Alan C. Opsahl, Jan Schreiber, Sharon M. O’Neill, Michael Marconi, Jessie Qian, Santos Carvajal-Gonzalez, Barbara Tate, Anthony J. Milici, Kelly R. Bales, Diane T. Stephenson, High throughput object-based image analysis of β-amyloid plaques in human and transgenic mouse brain, Journal of Neuroscience Methods, 2012, 204, 1, 179

    CrossRef

  74. 74
    Malgorzata Duszczyk, Magdalena Kuszczyk, Maitea Guridi, Jerzy W. Lazarewicz, Martin J. Sadowski, In vivo hippocampal microdialysis reveals impairment of NMDA receptor–cGMP signaling in APPSW and APPSW/PS1L166P Alzheimer’s transgenic mice, Neurochemistry International, 2012, 61, 7, 976

    CrossRef

  75. 75
    Johannes vom Berg, Stefan Prokop, Kelly R Miller, Juliane Obst, Roland E Kälin, Ileana Lopategui-Cabezas, Anja Wegner, Florian Mair, Carola G Schipke, Oliver Peters, York Winter, Burkhard Becher, Frank L Heppner, Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline, Nature Medicine, 2012, 18, 12, 1812

    CrossRef

  76. 76
    Katja Scheffler, Markus Krohn, Tina Dunkelmann, Jan Stenzel, Bruno Miroux, Saleh Ibrahim, Oliver von Bohlen und Halbach, Hans-Jochen Heinze, Lary C. Walker, Jörg A. Gsponer, Jens Pahnke, Mitochondrial DNA polymorphisms specifically modify cerebral β-amyloid proteostasis, Acta Neuropathologica, 2012, 124, 2, 199

    CrossRef

  77. 77
    Géraldine Poisnel, Martine Dhilly, Olivier Moustié, Jérôme Delamare, Ahmed Abbas, Denis Guilloteau, Louisa Barré, PET imaging with [18F]AV-45 in an APP/PS1-21 murine model of amyloid plaque deposition, Neurobiology of Aging, 2012, 33, 11, 2561

    CrossRef

  78. 78
    Daniela Hartl, Victoria Schuldt, Stephanie Forler, Claus Zabel, Joachim Klose, Michael Rohe, Presymptomatic Alterations in Energy Metabolism and Oxidative Stress in the APP23 Mouse Model of Alzheimer Disease, Journal of Proteome Research, 2012, 11, 6, 3295

    CrossRef

  79. 79
    Jemila Houacine, Tristan Bolmont, Lorène Aeschbach, Mustapha Oulad-Abdelghani, Patrick C. Fraering, Selective neutralization of APP-C99 with monoclonal antibodies reduces the production of Alzheimer's Aβ peptides, Neurobiology of Aging, 2012, 33, 11, 2704

    CrossRef

  80. 80
    Alison Hamilton, Christian Holscher, The effect of ageing on neurogenesis and oxidative stress in the APPswe/PS1deltaE9 mouse model of Alzheimer's disease, Brain Research, 2012, 1449, 83

    CrossRef

  81. 81
    Ana F. Nunes, Joana D. Amaral, Adrian C. Lo, Maria B. Fonseca, Ricardo J. S. Viana, Zsuzsanna Callaerts-Vegh, Rudi D’Hooge, Cecília M. P. Rodrigues, TUDCA, a Bile Acid, Attenuates Amyloid Precursor Protein Processing and Amyloid-β Deposition in APP/PS1 Mice, Molecular Neurobiology, 2012, 45, 3, 440

    CrossRef

  82. 82
    Axel Montagne, Maxime Gauberti, Richard Macrez, Amandine Jullienne, Aurélien Briens, Jean-Sébastien Raynaud, Gaelle Louin, Alain Buisson, Benoit Haelewyn, Fabian Docagne, Gilles Defer, Denis Vivien, Eric Maubert, Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders, NeuroImage, 2012, 63, 2, 760

    CrossRef

  83. 83
    Simon Gengler, Paula L. McClean, Ruth McCurtin, Victor A. Gault, Christian Hölscher, Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice, Neurobiology of Aging, 2012, 33, 2, 265

    CrossRef

  84. 84
    Amantha Thathiah, Katrien Horré, An Snellinx, Elke Vandewyer, Yunhong Huang, Marta Ciesielska, Gerdien De Kloe, Sebastian Munck, Bart De Strooper, β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease, Nature Medicine, 2012, 19, 1, 43

    CrossRef

  85. 85
    Sabine Scheibe, Mario M. Dorostkar, Christian Seebacher, Rainer Uhl, Frank Lison, Jochen Herms, 4D in in vivo 2-photon laser scanning fluorescence microscopy with sample motion in 6 degrees of freedom, Journal of Neuroscience Methods, 2011, 200, 1, 47

    CrossRef

  86. 86
    Peizhong Mao, P. Hemachandra Reddy, Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: Implications for early intervention and therapeutics, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011, 1812, 11, 1359

    CrossRef

  87. 87
    Markus Krohn, Cathleen Lange, Jacqueline Hofrichter, Katja Scheffler, Jan Stenzel, Johannes Steffen, Toni Schumacher, Thomas Brüning, Anne-Sophie Plath, Franziska Alfen, Anke Schmidt, Felix Winter, Katja Rateitschak, Andreas Wree, Jörg Gsponer, Lary C. Walker, Jens Pahnke, Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice, Journal of Clinical Investigation, 2011, 121, 10, 3924

    CrossRef

  88. 88
    Stefan J. Teipel, Ralph Buchert, Johannes Thome, Harald Hampel, Jens Pahnke, Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression, Progress in Neurobiology, 2011, 95, 4, 547

    CrossRef

  89. 89
    Niels J. Rupp, Bettina M. Wegenast-Braun, Rebecca Radde, Michael E. Calhoun, Mathias Jucker, Early onset amyloid lesions lead to severe neuritic abnormalities and local, but not global neuron loss in APPPS1 transgenic mice, Neurobiology of Aging, 2011, 32, 12, 2324.e1

    CrossRef

  90. 90
    Cristina Marchetti, Hélène Marie, Hippocampal synaptic plasticity in Alzheimer’s disease: what have we learned so far from transgenic models?, Reviews in the Neurosciences, 2011, 22, 4

    CrossRef

  91. 91
    Leon M. Tai, Katherine L. Youmans, Lisa Jungbauer, Chunjiang Yu, Mary Jo LaDu, Introducing HumanAPOEinto AβTransgenic Mouse Models, International Journal of Alzheimer's Disease, 2011, 2011, 1

    CrossRef

  92. 92
    Athanasios Zovoilis, Hope Y Agbemenyah, Roberto C Agis-Balboa, Roman M Stilling, Dieter Edbauer, Pooja Rao, Laurent Farinelli, Ivana Delalle, Andrea Schmitt, Peter Falkai, Sanaz Bahari-Javan, Susanne Burkhardt, Farahnaz Sananbenesi, Andre Fischer, microRNA-34c is a novel target to treat dementias, The EMBO Journal, 2011, 30, 20
  93. 93
    Stefanie Hahn, Tanja Brüning, Julia Ness, Eva Czirr, Sandra Baches, Harrie Gijsen, Carsten Korth, Claus U. Pietrzik, Bruno Bulic, Sascha Weggen, Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer’s disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure, Journal of Neurochemistry, 2011, 116, 3
  94. 94
    Christoph Roesli, Tim Fugmann, Beatrice Borgia, Christoph Schliemann, Dario Neri, Mathias Jucker, The accessible cerebral vascular proteome in a mouse model of cerebral β-amyloidosis, Journal of Proteomics, 2011, 74, 4, 539

    CrossRef

  95. 95
    Enrica Boda, Francesca Viganò, Patrizia Rosa, Marta Fumagalli, Vivien Labat-Gest, Filippo Tempia, Maria P. Abbracchio, Leda Dimou, Annalisa Buffo, The GPR17 receptor in NG2 expressing cells: Focus on in vivocell maturation and participation in acute trauma and chronic damage, Glia, 2011, 59, 12
  96. 96
    Amantha Thathiah, Bart De Strooper, The role of G protein-coupled receptors in the pathology of Alzheimer's disease, Nature Reviews Neuroscience, 2011, 12, 2, 73

    CrossRef

  97. 97
    Alzbeta Trancikova, David Ramonet, Darren J. Moore, Animal Models of Human Disease, 2011,

    CrossRef

  98. 98
    Stephan Röskam, Frauke Neff, Rainer Schwarting, Michael Bacher, Richard Dodel, APP transgenic mice: The effect of active and passive immunotherapy in cognitive tasks, Neuroscience & Biobehavioral Reviews, 2010, 34, 4, 487

    CrossRef

  99. 99
    Teo Vargas, Cristina Ugalde, Carlos Spuch, Desiree Antequera, María J. Morán, Miguel A. Martín, Isidro Ferrer, Felix Bermejo-Pareja, Eva Carro, Aβ accumulation in choroid plexus is associated with mitochondrial-induced apoptosis, Neurobiology of Aging, 2010, 31, 9, 1569

    CrossRef

  100. 100
    Sungho Lee, Nicholas H. Varvel, Megan E. Konerth, Guixiang Xu, Astrid E. Cardona, Richard M. Ransohoff, Bruce T. Lamb, CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models, The American Journal of Pathology, 2010, 177, 5, 2549

    CrossRef

  101. 101
    Paula L. McClean, Victor A. Gault, Patrick Harriott, Christian Hölscher, Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease, European Journal of Pharmacology, 2010, 630, 1-3, 158

    CrossRef

  102. 102
    Thomas Wisniewski, Allal Boutajangout, Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models, Brain Structure and Function, 2010, 214, 2-3, 201

    CrossRef

  103. 103
    Janaky Coomaraswamy, Ellen Kilger, Heidrun Wölfing, Claudia Schäfer, Stephan A. Kaeser, Bettina M. Wegenast-Braun, Jasmin K. Hefendehl, Hartwig Wolburg, Matthew Mazzella, Jorge Ghiso, Michel Goedert, Haruhiko Akiyama, Francisco Garcia-Sierra, David P. Wolfer, Paul M. Mathews, Mathias Jucker, Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease, Proceedings of the National Academy of Sciences, 2010, 107, 17, 7969

    CrossRef

  104. You have full text access to this Open Access content104
    Anna Maria Calella, Mélissa Farinelli, Mario Nuvolone, Osvaldo Mirante, Rita Moos, Jeppe Falsig, Isabelle M. Mansuy, Adriano Aguzzi, Prion protein and Aβ-related synaptic toxicity impairment, EMBO Molecular Medicine, 2010, 2, 8
  105. 105
    Claus Zabel, Huu Phuc Nguyen, Sascha C. Hin, Daniela Hartl, Lei Mao, Joachim Klose, Proteasome and oxidative phoshorylation changes may explain why aging is a risk factor for neurodegenerative disorders, Journal of Proteomics, 2010, 73, 11, 2230

    CrossRef

  106. 106
    Christian Hölscher, Incretins and Insulin Secretion, 2010,

    CrossRef

  107. 107
    L. Serneels, J. Van Biervliet, K. Craessaerts, T. Dejaegere, K. Horre, T. Van Houtvin, H. Esselmann, S. Paul, M. K. Schafer, O. Berezovska, B. T. Hyman, B. Sprangers, R. Sciot, L. Moons, M. Jucker, Z. Yang, P. C. May, E. Karran, J. Wiltfang, R. D'Hooge, B. De Strooper,  -Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer's Disease, Science, 2009, 324, 5927, 639

    CrossRef

  108. 108
    K. Ghosal, D. L. Vogt, M. Liang, Y. Shen, B. T. Lamb, S. W. Pimplikar, Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain, Proceedings of the National Academy of Sciences, 2009, 106, 43, 18367

    CrossRef

  109. 109
    Christina Priller, Gerda Mitteregger, Sandra Paluch, Neville Vassallo, Matthias Staufenbiel, Hans A. Kretzschmar, Mathias Jucker, Jochen Herms, Excitatory synaptic transmission is depressed in cultured hippocampal neurons of APP/PS1 mice, Neurobiology of Aging, 2009, 30, 8, 1227

    CrossRef

  110. 110
    Stefan A Grathwohl, Roland E Kälin, Tristan Bolmont, Stefan Prokop, Georg Winkelmann, Stephan A Kaeser, Jörg Odenthal, Rebecca Radde, Therese Eldh, Sam Gandy, Adriano Aguzzi, Matthias Staufenbiel, Paul M Mathews, Hartwig Wolburg, Frank L Heppner, Mathias Jucker, Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia, Nature Neuroscience, 2009, 12, 11, 1361

    CrossRef

  111. 111
    Talib Abbas, Emilie Faivre, Christian Hölscher, Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease, Behavioural Brain Research, 2009, 205, 1, 265

    CrossRef

  112. 112
    Thomas van Groen, Inga Kadish, Katja Wiesehan, Susanne A. Funke, Dieter Willbold, In vitro and in vivo Staining Characteristics of Small, Fluorescent, Aβ42-Binding D-Enantiomeric Peptides in Transgenic AD Mouse Models, ChemMedChem, 2009, 4, 2
  113. 113
    Bettina M. Wegenast-Braun, Ana Fulgencio Maisch, Daniel Eicke, Rebecca Radde, Martin C. Herzig, Matthias Staufenbiel, Mathias Jucker, Michael E. Calhoun, Independent Effects of Intra- and Extracellular Aβ on Learning-Related Gene Expression, The American Journal of Pathology, 2009, 175, 1, 271

    CrossRef

  114. 114
    Sandra Pereson, Hans Wils, Gernot Kleinberger, Eileen McGowan, Mado Vandewoestyne, Bianca Van Broeck, Geert Joris, Ivy Cuijt, Dieter Deforce, Michael Hutton, Christine Van Broeckhoven, Samir Kumar-Singh, Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models, The Journal of Pathology, 2009, 219, 2
  115. 115
    A. Thathiah, K. Spittaels, M. Hoffmann, M. Staes, A. Cohen, K. Horre, M. Vanbrabant, F. Coun, V. Baekelandt, A. Delacourte, D. F. Fischer, D. Pollet, B. De Strooper, P. Merchiers, The Orphan G Protein-Coupled Receptor 3 Modulates Amyloid-Beta Peptide Generation in Neurons, Science, 2009, 323, 5916, 946

    CrossRef

  116. 116
    L. Rajendran, A. Schneider, G. Schlechtingen, S. Weidlich, J. Ries, T. Braxmeier, P. Schwille, J. B. Schulz, C. Schroeder, M. Simons, G. Jennings, H.-J. Knolker, K. Simons, Efficient Inhibition of the Alzheimer's Disease  -Secretase by Membrane Targeting, Science, 2008, 320, 5875, 520

    CrossRef

  117. 117
    Gerhard Eichhoff, Marc Aurel Busche, Olga Garaschuk, In vivo calcium imaging of the aging and diseased brain, European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35, S1, 99

    CrossRef

  118. 118
    Henrieta Scholtzova, Youssef Z. Wadghiri, Moustafa Douadi, Einar M. Sigurdsson, Yong-Sheng Li, David Quartermain, Pradeep Banerjee, Thomas Wisniewski, Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging, Journal of Neuroscience Research, 2008, 86, 12
  119. 119
    Florian V. Ermini, Stefan Grathwohl, Rebecca Radde, Masohiro Yamaguchi, Matthias Staufenbiel, Theo D. Palmer, Mathias Jucker, Neurogenesis and Alterations of Neural Stem Cells in Mouse Models of Cerebral Amyloidosis, The American Journal of Pathology, 2008, 172, 6, 1520

    CrossRef

  120. 120
    Rebecca Radde, Cecilia Duma, Michel Goedert, Mathias Jucker, The value of incomplete mouse models of Alzheimer’s disease, European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35, S1, 70

    CrossRef

  121. 121
    Frank Culicchia, Jian-Guo Cui, Yuan Yuan Li, Walter J. Lukiw, Upregulation of ??-amyloid precursor protein expression in glioblastoma multiforme, NeuroReport, 2008, 19, 9, 981

    CrossRef

  122. 122
    Charles Duyckaerts, Marie-Claude Potier, Benoît Delatour, Alzheimer disease models and human neuropathology: similarities and differences, Acta Neuropathologica, 2007, 115, 1, 5

    CrossRef

  123. 123
    Stephan A Kaeser, Martin C Herzig, Janaky Coomaraswamy, Ellen Kilger, Maj-Linda Selenica, David T Winkler, Matthias Staufenbiel, Efrat Levy, Anders Grubb, Mathias Jucker, Cystatin C modulates cerebral β-amyloidosis, Nature Genetics, 2007, 39, 12, 1437

    CrossRef

  124. 124
    Simon Gengler, Victor A. Gault, Patrick Harriott, Christian Hölscher, Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25–35) are dependent on stimulation-protocol and genetic background, Experimental Brain Research, 2007, 179, 4, 621

    CrossRef

  125. 125
    John C. Fiala, Mechanisms of amyloid plaque pathogenesis, Acta Neuropathologica, 2007, 114, 6, 551

    CrossRef

  126. 126
    Christian Hölscher, Roles of Glucagon-Like Peptide and Glucose-Dependent Insolinotropic Polypeptide Hormones in Brain Function and Neurodegeneration,